Healthcare Global boosts investment in Kenyan cancer care subsidiary

Healthcare Global Enterprises Limited (HCG) announced on November 12, 2025, that its board of directors approved an investment of up to 10% of the shares in its step-down subsidiary, Cancer Care Kenya Limited (CCK). This all-cash acquisition, with a cost not exceeding INR 7 Crore, aims to support CCK's business expansion in Kenya. CCK, incorporated on February 27, 2007, operates a cancer hospital providing radiation and chemotherapy services, including a 15-bedded Day Care Centre in Nairobi.

For the financial year ended March 31, 2025, CCK reported a turnover of INR 42.53 Crore and a profit after tax of INR 10.83 Crore. The investment does not require any governmental or regulatory approvals and is expected to be completed by March 31, 2026.

Additionally, HCG will issue a Standby Letter of Credit (SBLC) to guarantee credit facilities of approximately $1.8 million for CCK. This guarantee, classified as a contingent liability for HCG, is expected to cover up to 105% of CCK's outstanding loan under this arrangement and will be released upon full repayment.